Kura Oncology, Inc. KURA
7.27 USD +0.47 (+6.91%)
At closeNov 6, 2026, 4:42 PM EST
7.27 0.00 0.00%
After hours · Nov 6, 4:42 PM ET
6.75 Day range 7.40
6.80 52-week range 13.59
- YTD
- -30.03%
- 1 year
- -28.44%
News
benzinga.com Reported Earlier: Kura Oncology And Kyowa Kirin To Present Eight Ziftomenib Abstracts At ASH 2026, Highlighting Promising AML Combination Data And Expanded Clinical Potential – Two oral presentations to feature first ziftomenib combination data with quizartinib in newly diagnosed and gilteritinib in relapsed/refractory NPM1/FLT3 co-mutated AML –– Longer-term Phase 1b data…
globenewswire.com Kura Oncology and Kyowa Kirin to Present First Ziftomenib-FLT3 Inhibitor Clinical Data at ASH 2026 – Two oral presentations to feature first ziftomenib combination data with quizartinib in newly diagnosed and gilteritinib in relapsed/refractory NPM1/FLT3 co-mutated AML –
globenewswire.com Kura Oncology to Report Third Quarter Financial Results on November 10 SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced it will report…
benzinga.com Caspian Therapeutics, Kura Oncology Plan To Devise Development Strategy For Caspian's KO-7246 Oral Menin Inhibitor Designed For Diabetes And Other Chronic Metabolic Diseases Caspian Therapeutics, Inc. ("Caspian") and Kura Oncology, Inc. (Nasdaq: KURA, "Kura") plan to outline the development strategy for KO-7246, Caspian’s selective, oral menin inhibitor designed for…
benzinga.com This Toll Brothers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday Analysts initiated bullish coverage on Vita Coco, Toll Brothers, Civeo, Teva and Kura Oncology, with price targets of $70, $159, $42, $55 and $30.
benzinga.com JP Morgan Initiates Coverage On Kura Oncology with Overweight Rating, Announces Price Target of $30 JP Morgan analyst Priyanka Grover initiates coverage on Kura Oncology (NASDAQ:KURA) with a Overweight rating and announces Price Target of $30.
benzinga.com Caspian Therapeutics And Kura Oncology Released Comprehensive Preclinical Data Supporting KO-7246 For Diabetes Caspian Therapeutics, Inc. ("Caspian") and Kura Oncology, Inc. (NASDAQ:KURA, "Kura"))) today announced comprehensive preclinical data supporting KO-7246 as a potential best-in-class menin inhibitor…
benzinga.com Kura Oncology Q2 2026 Earnings Call Transcript On Wednesday, Kura Oncology (NASDAQ:KURA) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to…
benzinga.com Kura Oncology Pivots Diabetes Strategy Into $50 Million Subsidiary Kura Oncology launches Caspian Therapeutics with $50 million financing to advance menin inhibitor for diabetes and cardiometabolic diseases.
benzinga.com Kura Oncology Appoints Jennifer Fulk As CFO, Effective September 8 – Seasoned public company CFO with deep biopharmaceutical finance experience across commercial operations, R&D portfolio management, investor relations, and capital allocation – SAN DIEGO, Sept. 08,…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 35.9% to $7.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.2 million. Biodexa…
benzinga.com Why Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket Shares of Cadeler A/S (NYSE: CDLR) surged in pre-market trading after reporting strong financial results for the first half of 2026. Revenue and profit increased significantly, and full-year guidance…- benzinga.com Citizens Reiterates Market Outperform on Kura Oncology, Maintains $24 Price Target Citizens analyst Reni J. Benjamin reiterates Kura Oncology (NASDAQ:KURA) with a Market Outperform and maintains $24 price target.
benzinga.com Duos Technologies Posts Upbeat Q2 Results, Joins Amylyx Pharmaceuticals, Weave Communications And Other Big Stocks Moving Higher On Tuesday US stocks down, Nasdaq falls 300+ points. Duos Tech shares rise on better Q2 results. Many other big stocks gain, including Duolingo, Intuit, and Newsmax.
benzinga.com Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday Nasdaq Composite gained 200 points on Thursday, while Accelerant Holdings (NYSE: ARX) rose 44.2% after being acquired by Thoma Bravo and reporting strong Q2 results. Other top gainers include Omeros…- benzinga.com Wedbush Maintains Outperform on Kura Oncology, Raises Price Target to $38 Wedbush analyst Robert Driscoll maintains Kura Oncology (NASDAQ:KURA) with a Outperform and raises the price target from $36 to $38.
- benzinga.com Kura Oncology Q2 EPS $(0.77) Beats $(0.87) Estimate, Sales $20.874M Miss $21.420M Estimate Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.77) per share which beat the analyst consensus estimate of $(0.87) by 11.49 percent. This is a 2.67 percent decrease over losses of…
benzinga.com Kura Oncology Announces Publication Of Manuscript In Blood, Journal Of The American Society Of Hematology, Detailing Discovery And Preclinical Development Of Ziftomenib – Publication details the discovery and preclinical characterization of ziftomenib, including its potency, selectivity, and mechanism of action –– Findings demonstrate differentiated menin binding…
benzinga.com QuickLogic Posts Downbeat Q1 Results, Joins Resideo Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session Dow futures down 100 points. QuickLogic (QUIK) falls after reporting worse-than-expected Q1 results. Other stocks also dip in pre-market trading.
benzinga.com Earnings Scheduled For May 12, 2026 
benzinga.com Kura Oncology Advances Kidney Cancer Program With Solid Early-Stage Results Kura Oncology says kidney cancer trial data shows 44% response rate and strong disease control; analysts maintain Buy ratings.- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Earnings Scheduled For March 5, 2026
benzinga.com Earnings Scheduled For November 4, 2025 - benzinga.com 10 Health Care Stocks With Whale Alerts In Today's Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - benzinga.com Earnings Scheduled For August 7, 2025
benzinga.com Earnings Scheduled For May 1, 2025 
benzinga.com Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - benzinga.com Earnings Scheduled For February 26, 2025
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
benzinga.com Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings - benzinga.com Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
- benzinga.com Earnings Scheduled For February 27, 2024 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
- benzinga.com Earnings Scheduled For November 2, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 647 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 386 stocks made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During the session on Thursday, 461 stocks hit new 52-week lows.
- benzinga.com Earnings Scheduled For August 3, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
- benzinga.com Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial…
- benzinga.com Earnings Scheduled For May 10, 2023 Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 104 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 185 companies achieved new lows for the year.
- benzinga.com Earnings Scheduled For February 23, 2023 Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023 - benzinga.com Cramer Is Holding This Biotech Stock On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended holding Biomarin Pharmaceutical Inc (NASDAQ: BMRN).
- benzinga.com Earnings Scheduled For November 3, 2022 Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
- benzinga.com Earnings Scheduled For August 3, 2022 Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report quarterly earnings at $0.79 per share on revenue of $1.15 billion.